Literature DB >> 17138246

Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors.

Silvia Bucciarelli1, Ricard Cervera, Gerard Espinosa, José A Gómez-Puerta, Manuel Ramos-Casals, Josep Font.   

Abstract

In order to know the causes of death and the prognostic factors, our group analyzed 250 patients included until February 2005 in the web-site based international registry of patients with catastrophic antiphospholipid syndrome (APS) ("CAPS Registry") (http://www.med.ub.es/MIMMUN/FORUM/CAPS.HTM). Cerebral involvement, mainly consisting of stroke, followed by cardiac involvement and infections were considered the main causes of death in patients with catastrophic APS. The presence of systemic lupus erythematosus was related with higher mortality. According to the results of this analysis, anticoagulation plus steroids plus plasma exchange should be the first line of therapy in patients with catastrophic APS.

Entities:  

Mesh:

Year:  2006        PMID: 17138246     DOI: 10.1016/j.autrev.2006.06.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  15 in total

Review 1.  Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors:  Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.317

Review 2.  Pediatric antiphospholipid syndrome.

Authors:  Jacqueline A Madison; Yu Zuo; Jason S Knight
Journal:  Eur J Rheumatol       Date:  2019-12-03

Review 3.  Probable Catastrophic Antiphospholipid Syndrome with Intracerebral Hemorrhage Secondary to Epstein-Barr Viral Infection.

Authors:  Mark P Plummer; Adam M H Young; Ronan O'Leary; Maxwell S Damian; Andrea Lavinio
Journal:  Neurocrit Care       Date:  2018-02       Impact factor: 3.210

4.  APS--more systemic disease than SLE.

Authors:  Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

Review 5.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

Review 6.  Antiphospholipid antibodies in critically ill patients.

Authors:  Juliana Vassalo; Nelson Spector; Ernesto de Meis; Márcio Soares; Jorge Ibrain Figueira Salluh
Journal:  Rev Bras Ter Intensiva       Date:  2014 Apr-Jun

7.  Extensive vascular occlusions as initial presentations of systemic lupus erythematosis. A case report and review of literature.

Authors:  Mohamed Elsharawy; Manal Hasan; Ibrahiem Saeed Abdul-Rahman; Bandar Al-Dhofairy; Ayman Elsaid
Journal:  Avicenna J Med       Date:  2015 Apr-Jun

Review 8.  Antiphospholipid syndrome.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Arthritis Res Ther       Date:  2008-12-15       Impact factor: 5.156

Review 9.  Developments in the clinical understanding of lupus.

Authors:  Mary K Crow
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

Review 10.  Cardiovascular involvement in autoimmune diseases.

Authors:  Jenny Amaya-Amaya; Laura Montoya-Sánchez; Adriana Rojas-Villarraga
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.